Clinical Trials Browser

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma × Injections × 90 days × Clear all

NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Phase 1 Recruiting

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma